期刊文献+

Rare cystic liver lesions: A diagnostic and managing challenge 被引量:4

Rare cystic liver lesions: A diagnostic and managing challenge
下载PDF
导出
摘要 Cystic formations within the liver are a frequent finding among populations.Besides the common cystic lesions,like simple liver cysts,rare cystic liver lesions like cystadenocarcinoma should also be considered in the differential diagnosis.Thorough knowledge of each entity’s nature and course are key elements to successful treatment.Detailed search in PubMed,Cochrane Database,and international published literature regarding rare cystic liver lesions was carried out.In our research are included not only primary rare lesions like cystadenoma,hydatid cyst,and polycystic liver disease,but also secondary ones like metastasis from gastrointestinal stromal tumors lesions.Up-to date knowledge regarding diagnosis and management of rare cystic liver lesions is provided.A diagnostic and therapeutic algorithm is also proposed.The need for a multidisciplinary approach by a team including radiologists and surgeons familiar with liver cystic entities,diagnostic tools,and treatment modalities is stressed.Patients with cystic liver lesions must be carefully evaluated by a multidisciplinary team,in order to receive the most appropriate treatment,since many cystic liver lesions have a malignant potential and evolution. Cystic formations within the liver are a frequent finding among populations. Besides the common cystic lesions, like simple liver cysts, rare cystic liver lesions like cystadenocarcinoma should also be considered in the differential diagnosis. Thorough knowledge of each entity’s nature and course are key elements to successful treatment. Detailed search in PubMed, Cochrane Database, and international published literature regarding rare cystic liver lesions was carried out. In our research are included not only primary rare lesions like cystadenoma, hydatid cyst, and polycystic liver disease, but also secondary ones like metastasis from gastrointestinal stromal tumors lesions. Up-to date knowledge regarding diagnosis and management of rare cystic liver lesions is provided. A diagnostic and therapeutic algorithm is also proposed. The need for a multidisciplinary approach by a team including radiologists and surgeons familiar with liver cystic entities, diagnostic tools, and treatment modalities is stressed. Patients with cystic liver lesions must be carefully evaluated by a multidisciplinary team, in order to receive the most appropriate treatment, since many cystic liver lesions have a malignant potential and evolution.
出处 《World Journal of Gastroenterology》 SCIE CAS 2013年第43期7603-7619,共17页 世界胃肠病学杂志(英文版)
关键词 LIVER CYST CYSTIC tumor Hepatic lesion Gastrointestinal stromal tumors Metastases CYSTADENOMA CYSTADENOCARCINOMA HYDATID CYST Polycystic LIVER disease Caroli Echinococcus Liver cyst Cystic tumor Hepatic lesion Gastrointestinal stromal tumors Metastases Cystadenoma Cystadenocarcinoma Hydatid cyst Polycystic liver disease Caroli Echinococcus
  • 相关文献

参考文献5

二级参考文献22

  • 1Fei Fei She1,Dong Hui Su1,Jian Yin Lin2,Lin Ying Zhou3 1Department of Microbiology, Fujian Medical University. Fuzhou 350004, Fujian Province, China2Department of Molecular Medicine, Fujian Medical University, Fuzhou 350004, Fujian Province, China 3Laboratory of Electron Microscope, Fujian Medical University, Fuzhou 350004. Fujian Province. ChinaFei Fei She. graduated from Fujian Medical University as a postgraduate in 1991, now associate professor of microbiology and immunology, specialized in molecular biology of pathogen, having 15 papers published..Virulence and potential pathogenicity of coccoid Helicobacter pylori induced by antibiotics[J].World Journal of Gastroenterology,2001,7(2):254-258. 被引量:18
  • 2[1]Hirota S,Isozaki K,Moriyama Y,Hashimoto K,Nishida T,Ishiguro S,Kawano K,Hanada M,Kurata A,Takeda M,Muhammad Tunio G,Matsuzawa Y,Kanakura Y,Shinomura Y,Kitamura Y.Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.Science 1998;279:577-580
  • 3[2]Joensuu H,Roberts PJ,Sarlomo-Rikala M,Andersson LC,Tervahartiala P,Tuveson D,Silberman S,Capdeville R,Dimitrijevic S,Druker B,Demetri GD.Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.N Engl J Med 2001;344:1052-1056
  • 4[3]Demetri GD,von Mehren M,Blanke CD,Van den Abbeele AD,Eisenberg B,Roberts PJ,Heinrich MC,Tuveson DA,Singer S,Janicek M,Fletcher JA,Silverman SG,Silberman SL,Capdeville R,Kiese B,Peng B,Dimitrijevic S,Druker BJ,Corless C,Fletcher CD,Joensuu H.Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.N Engl J Med 2002;347:472-480
  • 5[4]Verweij J,Casali PG,Zalcberg J,LeCesne A,Reichardt P,Blay JY,Issels R,van Oosterom A,Hogendoorn PC,Van Glabbeke M,Bertulli R,Judson I.Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib:randomised trial.Lancet 2004;364:1127-1134
  • 6[5]Scaife CL,Hunt KK,Patel SR,Benjamin RS,Burgess MA,Chen LL,Trent J,Raymond AK,Cormier JN,Pisters PW,Pollock RE,Feig BW.Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate? Am J Surg 2003;186:665-669
  • 7[6]Bauer S,Hartmann JT,de Wit M,Lang H,Grabellus F,Antoch G,Niebel W,Erhard J,Ebeling P,Zeth M,Taeger G,Seeber S,Flasshove M,Schutte J.Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib.Int J Cancer 2005;117:316-325
  • 8[7]Chacon M,Roca E,Huertas E,Loria FS,Domenechini E.CASE 3.Pathologic complete remission of metastatic gastrointestinal stromal tumor after imatinib mesylate.J Clin Onco12005;23:1580-1582
  • 9[8]Salazar M,Barata A,Andre S,Venancio J,Francisco I,Cravo M,Nobre-Leitao C.First report of a complete pathological response of a pelvic GIST treated with imatinib as neoadjuvant therapy.Gut 2006;55:585-586
  • 10[9]Bonvalot S,Eldweny H,Pechoux CL,Vanel D,Terrier P,Cavalcanti A,Robert C,Lassau N,Cesne AL.Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era.Ann Surg Oncol 2006;13:1596-1603

共引文献87

同被引文献16

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部